Speaker Details

Benjamin Kaffenberger, MD, FAAD

Benjamin Kaffenberger, MD, FAAD

SESSIONS

F072 The Morbilliform Eruption: Differentiation and Treatment of Viral, Low-risk Drug, Severe Cutaneous Adverse Reactions, and GVHD
Mar 9, 2024 • 3:30 PM - 12:00 AM • Room 6C
S055 Consultative Dermatology for the Hospitalized Patient
Mar 11, 2024 • 9:00 AM - 12:00 AM • Room 30D

HANDOUTS

Login to view handouts

DISCLOSURES

Almirall – Consultant (1099 relationship)(Honoraria); Boehringer Ingelheim – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Dermatology Foundation – Investigator(Grants/Research Funding); Eli Lilly and Company – Consultant (1099 relationship)(Honoraria); HCW Biologics – Investigator(Grants/Research Funding); InflaRx – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Janssen Biotech – Investigator(Grants/Research Funding); Leo Pharma – Investigator(Grants/Research Funding); National Comprehensive Cancer Network – Speaker(Honoraria); Pfizer Inc. – Data Safety Monitoring Board(Fees); Protillion Biosciences – Consultant (1099 relationship)(Stock Options);